AbbVie Earnings, Revenue miss in Q4
Investing.com - AbbVie (NYSE:ABBV) reported fourth quarter earnings that missed analysts' expectations on Friday and revenue that fell short of forecasts.
The firm reported earnings per share of $1.9 on revenue of $8.31B. Analysts polled by Investing.com anticipated EPS of $1.93 on revenue of $8.39B. That compared to EPS of $1.48 on revenue of $7.74B in the same period a year earlier. The company had reported EPS of $2.14 on revenue of $8.24B in the previous quarter.
AbbVie shares lost 1.27% to trade at $84.790 in pre-market trade following the report.
AbbVie follows other major Healthcare sector earnings this month
On Tuesday, J&J reported fourth quarter EPS of $1.97 on revenue of $20.39B, compared to forecasts of EPS of $1.95 on revenue of $20.2B.
Abbott Labs earnings matched analyst's expectations on Wednesday, with fourth quarter EPS of $0.81 on revenue of $7.77B. Investing.com analysts expected EPS of $0.81 on revenue of $7.81B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar
Related Articles
Apple sees sales largely below Wall Street as iPhone demand weak
